Aminorroaya, Arya http://orcid.org/0000-0003-3197-2657
Dhingra, Lovedeep S. http://orcid.org/0000-0002-5664-4126
Oikonomou, Evangelos K. http://orcid.org/0000-0003-4362-0720
Saadatagah, Seyedmohammad
Thangaraj, Phyllis
Vasisht Shankar, Sumukh http://orcid.org/0009-0005-3034-0641
Spatz, Erica S.
Khera, Rohan http://orcid.org/0000-0001-9467-6199
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K23HL153775)
Doris Duke Charitable Foundation (2022060)
Article History
Received: 31 January 2024
Accepted: 2 April 2024
First Online: 9 May 2024
Competing interests
: R.K. is an associate editor at <i>JAMA</i> and receives research grant support, through Yale, from Bristol‐Myers Squibb, Novo Nordisk and BridgeBio. R.K. also receives support from the Blavatnik Foundation through the Blavatnik Fund for Innovation at Yale. R.K. is a cofounder of Ensight-AI, and R.K. and E.K.O. are cofounders of Evidence2Health, both representing precision health platforms to improve evidence-based cardiovascular care. E.K.O. has served as a consultant to Caristo Diagnostics Ltd. (Oxford, U.K.), unrelated to the current work. The other authors have no disclosures to report.